Stocks and Investing Stocks and Investing
Thu, September 22, 2022
[ 12:00 AM ] - United States, WOPRAI
Stephen Byrd Maintained (AEE) at Buy with Decreased Target to $99 on, Sep 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Jackson Ader Initiated (ADSK) at Strong Sell and Held Target at $206 on, Sep 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Jackson Ader Initiated (ADBE) at Hold and Held Target at $354 on, Sep 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Jason Kupferberg Maintained (ACN) at Strong Buy with Decreased Target to $358 on, Sep 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
David Togut Maintained (ACN) at Buy with Decreased Target to $319 on, Sep 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Bryan Bergin Maintained (ACN) at Buy and Held Target at $325 on, Sep 22nd, 2022
Wed, September 21, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Cheng Initiated (ACET) at Buy and Held Target at $23 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Cindy Motz Maintained (ACCD) at Strong Buy with Increased Target to $15 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Keith Bachman Maintained (ACN) at Hold with Decreased Target to $315 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Daniel Perlin Reiterated (ACN) at Buy and Held Target at $357 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Maintained (ACB) at Hold with Decreased Target to $30 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Cheng Initiated (ADCT) at Buy and Held Target at $5 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
George Gianarikas Initiated (WOLF) at Strong Buy and Held Target at $140 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Atidrip Modak Maintained (WFRD) at Strong Buy with Increased Target to $38 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
David Begleiter Maintained (WLK) at Strong Buy with Decreased Target to $100 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Vijay Rakesh Downgraded (WDC) to Hold and Decreased Target to $40 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Curt Woodworth Maintained (AA) at Hold with Decreased Target to $50 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Tim Long Upgraded (ANET) to Buy and Held Target at $131 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Brett Linzey Maintained (ALLE) at Strong Buy with Decreased Target to $114 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
James Shanahan Upgraded (BRK) to Strong Buy on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Edward Engel Initiated (BRAG) at Strong Buy and Held Target at $9 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Maintained (BYND) at Sell with Decreased Target to $8 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Roger Read Maintained (VLO) at Buy with Increased Target to $131 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
John Royall Maintained (VLO) at Buy and Held Target at $151 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Abhi Agarwal Maintained (TECK) at Strong Buy with Decreased Target to $43 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Cheng Initiated (XNCR) at Buy and Held Target at $37 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Kyle Peterson Initiated (STER) at Strong Buy and Held Target at $27 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Corey Grady Initiated (TRUP) at Strong Buy and Held Target at $77 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Rick Wise Maintained (TMCI) at Strong Buy with Increased Target to $27 on, Sep 21st, 2022
[ 12:00 AM ] - United States, WOPRAI
Ryan Zimmerman Maintained (TMCI) at Strong Buy with Increased Target to $28 on, Sep 21st, 2022

Ryan Zimmerman Maintained (TMCI) at Strong Buy with Increased Target to $28 on, Sep 21st, 2022


Published on 2024-10-27 23:03:39 - WOPRAI, Ryan Zimmerman
  Print publication without navigation


Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $23 to $28 on, Sep 21st, 2022.

Ryan has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Ryan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ryan

  • Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $23 on, Wednesday, August 10th, 2022

Contributing Sources